Atorvastatin

• CAT Number: I001314
• CAS Number: 134523-00-5
• Molecular Formula: C₃₃H₃₅FN₂O₅
• Molecular Weight: 558.64
• Purity: ≥95%
• Target: Autophagy
• IUPAC Name: (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid
• InChI: InChI=1S/C33H35FN2O5/c1-21(2)31-30(33(41)35-25-11-7-4-8-12-25)29(22-9-5-3-6-10-22)32(23-13-15-24(34)16-14-23)36(31)18-17-26(37)19-27(38)20-28(39)40/h3-16,21,26-27,37-38H,17-20H2,1-2H3,(H,35,41)(H,39,40)/t26-,27-/m1/s1
• InChIKey: XUKUURHRXDUEBC-KAYWLYCHSA-N
• SMILES: CC(C)C1=C(C(=C(N1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4

Atorvastatin（Cat No.:I001314）is a potent lipid-lowering agent used to treat high cholesterol and prevent cardiovascular disease. As an HMG-CoA reductase inhibitor, it effectively reduces LDL cholesterol and triglycerides while increasing HDL cholesterol levels. Atorvastatin is pivotal in managing hyperlipidemia and mitigating the risk of heart attack and stroke. Its robust profile ensures widespread use in clinical practice. Essential for therapeutic strategies, Atorvastatin is also a valuable reference standard in pharmaceutical research, aiding in the development and quality control of related medications.